About Howard Goldstein
Form D filings for Acenxion Biosytems from 2023 to 2024 list Howard Goldstein as director.
Howard Goldstein first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name Howard Goldstein in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Howard Goldstein works with at each company, as listed on that company's latest Form D.
Acenxion Biosytems, Inc. · Form D, Aug 14, 2024
BS
Brian Struchtemeyer
Executive officer and director
RS
Roy Swiger
CEO and director
WC
Wayne Carter
Director